Importantly, NK cells seem to contribute to the deficit in IFN-γ, type I IFN and IL-12 genes, which are well characterized in SS patients [2, 29, 57], for whom IFN-α and IFN-γ are recommended as a treatment [58, 59]. The gene discussed is IFNG; the disease is synovial sarcoma.